Trial Profile
A Study Comparing Outcomes Of Stable Multiple Sclerosis (MS) Patients Continuing Intramuscular Interferon (IFN) beta-1a Therapy Versus Patients Switching To Another Interferon (IFN) Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Oct 2018
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary) ; Interferon
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 20 Oct 2018 Results assessing real-world outcomes of patients with multiple sclerosis published in the Advances in Therapy.
- 30 Nov 2016 New trial record